Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Determine which cash back credit card suits you best. Understand your spending habits to choose the right card for maximum rewards.
26,137 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
Gas costs ripple through every link of retail, from trucking to checkout. This article breaks down how could sudden j...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
Leveraged ETFs like TQQQ and QLD promise amplified Nasdaq-100 exposure, but they come with unique risks and timing re...
At CES 2026, Jensen Huang highlighted memory as AI's key bottleneck. This shift sent memory stocks like Micron and Sa...
Costco's strength goes beyond its membership fees. This article reveals how Kirkland Signature quietly grew into Cost...
The White House extended the deadline for Iran to reopen the Strait of Hormuz to April 6, sparking a fresh wave of oi...
Amazon is betting big on hardware to power AI at scale. This article explains how amazon's chips driving growth in AI...
Cardano has struggled to deliver on big promises, leaving many investors looking for cryptocurrencies that better buy...
As 2026 unfolds, a $1,000 split between XRP and SOL tests volatility, regulatory clarity, and upgrade momentum. This ...
AI-driven capex sustains a two-horse race in semiconductors. This piece weighs which is the better semi stock to buy ...